|
Hello Visitor,
Latest Relevant News Releases:
Ubiquitech Software Issues Company Update and Positive Outlook for Its Division HempLife Today
DENVER, CO--(Marketwired - Jan 13, 2016) - Ubiquitech Software Corp. (www.ubiquitechsoftware.com) (OTC PINK: UBQU), an International Technology and Services company that owns the division HempLife Today™ (www.hemplifetoday.com), is announcing year end highlights for 2015 as well as its exciting news and plans for 2016.
"We are thrilled with what we accomplished in 2015," said Tim Zorn, CEO of HempLife Today, "and our plans for 2016 are bigger and better than anything we did last year. This will keep us on our upward growth path and continue to establish us as the leader in our industry."
In 2015 HempLife Today™ grew exponentially and established itself as the leader in online sales of CBD Oil derived from Hemp. Gross sales for 2015 exceeded $3,500,000 (before discounts) for its proprietary brand of CannazALL™ CBD products. This includes its popular Tinctures, Oils, Vape Oils and Combo Packs.
Final sales figures for fiscal year 2015 are expected to be reported by the end of the month. The Company has also test marketed various new products and will be adding several items to the HempLife Today™ product offering in 2016.
In addition, HempLife Today™ added more than 15,000 new customers to its growing customer base in 2015.
For 2016 HempLife Today™ has even bigger plans. Including, but not limited to:
- A name and symbol change that will better reflect the nature of the Company's business and be more identifiable.
- An advertising budget substantially larger than in 2015.
- A new referral and affiliate program that will reward the current 15,000 customer base for assisting the Company in spreading the word about its products and acquiring new customers.
- A robust wholesale division to help put CannazALL™ products in retail outlets nationwide as well as internationally.
- New products, including CBD Capsules, a CBD topical skin cream, and new flavors for currently offered Tinctures.
- New marketing concepts and partnerships to ensure the growth of HempLife Today.com, HempLife™, and the CannazALL™ brands.
With more and more news stories covering the potential health benefits of CBD oil, and more states opening up to Medical Marijuana legalization, legal CBD from Hemp is garnering more publicity as well, and HempLife Today™ plans to continue to capitalize on this ever growing trend.
Public demand for (non-psychoactive) phyto-cannabinoids rich in CBD (Cannabidiol) has exploded, since their health benefits were dramatized publically on shows like the very popular CNN documentaries hosted by Dr. Sanjay Gupta, and hemp is the obvious choice for this purpose as oil extracted from hemp does contain high quantities of (non-psychoactive) phyto-cannabinoids.
"While Medical Marijuana is great and has many benefits, we will continue to stay solely on the legal in all 50 states Hemp side of the CBD industry," said James Ballas, CEO of Ubiquitech Software. "Because of this, and because of our exponential growth and marketing power, it is our position that our 2016 sales can be double or triple what we did in 2015 with HempLife Today."
With a current customer database of over 15,000, and the marketing and expansion plans in place for 2016, HempLife Today™ believes it can increase its customer base by 200% - 300% in 2016 to 30,000 - 50,000 customers. Coupled with a greater than 25% customer repurchase rate, the Company expects a significant increase in revenues and profits in 2016.
"Of our current customers in 2015 we experienced an approximate 25% repurchase rate from first time buyers, and an almost 75% repurchase rate from second time buyers," said Mr. Zorn. "This means that our customers like our products, benefit from them and continue to use them. This kind of customer is more apt to refer others to our products."
About Ubiquitech Software Corp.
Ubiquitech Software Corp., through its subsidiaries, is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries. HempLifeToday.com™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. HempLifeToday.com™ has developed two award winning lines of CannazALL™ CBD Oil.
The first line is the purest CBD available, our domestic blend grown in Colorado, USA, which is a premium Hemp strain approved by the Colorado State Agriculture Department. The second line is our European CBD which are grown with non-GMO plants at specific latitudes in specially chosen locations of Northern Europe.
This press release contains forward-looking statements. Words such as "expects", "intends'', "believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Contact:
Ubiquitech Software Corp.
Investor Relations
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
CanniMed Ltd. Receives Approval from Health Canada for Cannabis Oils - Patient Orders to be Fulfilled Immediately
SASKATOON, Jan. 12, 2016 /CNW/ - CanniMed Ltd. has successfully fulfilled all of Health Canada's inspection requirements and has been granted a Section 56 Supplemental Licence under the Marihuana for Medical Purposes Regulations (MMPR). This approval officially gives CanniMed the go ahead to begin sales of edible cannabis oils. Read Full Press Release.
PharmaCan Provides Update on the Closing of Sale of Shares of Peace Naturals
TORONTO, ON--(Marketwired - January 13, 2016) - PharmaCan Capital Corp. (TSX VENTURE: MJN)
PharmaCan Capital Corp. (TSX VENTURE: MJN) ("PharmaCan" or the "Company") announces that it has been advised that the proposed sale of the Barnes Family Trust's ("BFT") shares in The Peace Naturals Project Inc. ("PNP") has not been completed and that the offer to purchase these shares has been terminated (see press releases dated October 9, 2015, October 15, 2015, November 6, 2015, November 27, 2015 and December 18, 2015).
Read Full Press Release.
Heliospectra to Present at the Viridian Cannabis Investor Symposium in New York City
GOTHENBURG, SWEDEN and SAN FRANCISCO, CA--(Marketwired - Jan 12, 2016) - Heliospectra AB (OTCQB: HLSPY) (FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for plant research and greenhouse cultivation, is pleased to announce that it has been invited to present at the Viridian Cannabis Investor Symposium in New York City on January 13, 2016. Read Full Press Release.
That Marketing Solution, Inc. (OTCQB: TSTS) Announces Bioavailability Study Being Conducted on Their Micellized CBD Oil
SALT LAKE CITY, UT--(Marketwired - Jan 13, 2016) - That Marketing Solution, Inc. (OTCQB: TSTS), a developer and marketer of health related products and owner of the proprietary Aqua V Micellization process, announced that their micellized CBD oil is currently undergoing a bioavailability study to prove its superior bioavailability over other options. Read Full Press Release.
OWC Pharmaceutical Research Announces $750K Equity Purchase Agreement With Kodiak Capital Group
PETACH-TIKVA, Israel, January 11, 2016 /PRNewswire/ --
OWC Pharmaceutical Research Corp. (OTC: OWCP), an Israel-based pharmaceutical research company dedicated to the development of cannabinoid treatments, products and delivery technologies, today announced that it has entered into a $750,000 equity purchase agreement ("Agreement") with Kodiak Capital Group, LLC ("Kodiak"). Read Full Press Release.
|
